Insights in Dolutegravir-Resistance Pathways

被引：0
|
作者：
Mesplede, Thibault [1 ]
Gantner, Pierre [2 ,3 ,4 ]
机构：
[1] Erasmus MC, Viroscience Dept, Rotterdam, Netherlands
[2] Strasbourg Univ Hosp, Clin Virol Lab, Strasbourg, France
[3] Strasbourg Univ, INSERM, UMR S1109, Strasbourg, France
[4] Inst Virol, 3 rue Koeberle, F-67000 Strasbourg, France
来源：
CLINICAL INFECTIOUS DISEASES | 2024年 / 79卷 / 06期
关键词：
VIRAL REPLICATION; HIV-1; INTEGRASE; R263K MUTATION; DRUG-RESISTANCE; COMBINATION; EMERGENCE; SUBSTITUTIONS; SELECTION; FAILURE; M184I/V;
D O I：
10.1093/cid/ciae127
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1541 / 1542
页数：2
相关论文
共 50 条
  • [1] Insights in Dolutegravir-Resistance Pathways
    Mesplede, Thibault
    Gantner, Pierre
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1541 - 1542
  • [2] Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance
    Malet, Isabelle
    Thierry, Eloise
    Wirden, Marc
    Lebourgeois, Samuel
    Subra, Frederic
    Katlama, Christine
    Deprez, Eric
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Delelis, Olivier
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (10) : 2870 - 2880
  • [3] HIV-1 resistance to dolutegravir: update and new insights
    Wainberg, Mark A.
    Han, Ying-Shan
    JOURNAL OF VIRUS ERADICATION, 2015, 1 (01) : 13 - 16
  • [4] High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam
    Bwire, George M.
    Aiko, Beatrice Godwin
    Mosha, Idda H.
    Kilapilo, Mary S.
    Mangara, Alli
    Kazonda, Patrick
    Swai, Janeth P.
    Swalehe, Omary
    Jordan, Michael R.
    Vercauteren, Jurgen
    Sando, David
    Temba, David
    Shao, Amani
    Mauka, Wilhellmuss
    Decouttere, Catherine
    Vandaele, Nico
    Sangeda, Raphael Z.
    Killewo, Japhet
    Vandamme, Anne-Mieke
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam
    George M. Bwire
    Beatrice Godwin Aiko
    Idda H. Mosha
    Mary S. Kilapilo
    Alli Mangara
    Patrick Kazonda
    Janeth P. Swai
    Omary Swalehe
    Michael R. Jordan
    Jurgen Vercauteren
    David Sando
    David Temba
    Amani Shao
    Wilhellmuss Mauka
    Catherine Decouttere
    Nico Vandaele
    Raphael Z. Sangeda
    Japhet Killewo
    Anne-Mieke Vandamme
    Scientific Reports, 13
  • [6] High-level Dolutegravir Resistance Selection on Dolutegravir/Lamivudine
    Llibre, Josep M.
    Jou, Antoni
    Puig, Teresa
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1540 - 1541
  • [7] Dolutegravir/abacavir/dolutegravir/lamivudineDrug resistance: 2 case reports
    Reactions Weekly, 2018, 1727 (1) : 118 - 118
  • [8] Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclax
    Konopleva, Marina Y.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (01)
  • [9] Genetic Barrier to Resistance for Dolutegravir
    Llibre, Josep M.
    Pulido, Federico
    Garcia, Federico
    Garcia Deltoro, Miguel
    Blanco, Jose L.
    Delgado, Rafael
    AIDS REVIEWS, 2015, 17 (01) : 56 - 64
  • [10] Resistance to Dolutegravir-A Chink in the Armor?
    Kuritzkes, Daniel R.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (05): : 673 - 675
12345